GO:0070561 vitamin D receptor signaling pathway: Nuclear Receptor Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070561 describes a nuclear receptor-mediated signaling pathway that begins with vitamin D (calcitriol) binding to the intracellular vitamin D receptor (VDR) and ends with regulation of downstream cellular processes such as transcription.
• The VDR is a ligand-activated transcription factor that heterodimerizes with retinoid X receptor (RXR) and binds vitamin D response elements (VDREs) in target genes.
• VDR signaling controls calcium and phosphate homeostasis, bone metabolism, immune function, cell proliferation, and differentiation.
• Dysregulated VDR signaling is implicated in cancer, inflammatory bowel disease, psoriasis, diabetic nephropathy, and neuroblastoma.
• VDR activation modulates multiple pathways including Nrf2/HO-1, JAK/STAT, Wnt, and Hippo signaling.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential for dissecting causal roles of VDR pathway components.
Description
The vitamin D receptor signaling pathway (GO:0070561) is a biological process in which the active form of vitamin D, 1,25-dihydroxyvitamin D3 (calcitriol), binds to the intracellular vitamin D receptor (VDR), a member of the nuclear receptor superfamily, and initiates a cascade that ultimately regulates transcription of target genes. This pathway is highly conserved and plays pleiotropic roles in human physiology, from calcium homeostasis to immune modulation and cell cycle control. Understanding its molecular mechanism is critical because dysregulation of VDR signaling is associated with numerous diseases, including cancer, autoimmune disorders, and metabolic bone diseases. Researchers study this pathway using a combination of genomic, proteomic, and CRISPR-based approaches to identify causal genes and therapeutic targets.
vitamin D receptor signaling pathway At A Glance
| GO ID | GO:0070561 |
|---|---|
| GO term | vitamin D receptor signaling pathway |
| Ontology | biological_process |
| Synonym | calcitriol signaling pathway; intracellular vitamin D receptor signaling pathway; nuclear receptor-mediated vitamin D signaling pathway; VDR signaling pathway; vitamin D receptor signalling pathway |
| Major function | Ligand-activated transcription regulation of genes involved in calcium/phosphate homeostasis, immune response, cell proliferation, and differentiation |
| Key receptor | Vitamin D receptor (VDR), a nuclear receptor |
| Ligand | 1,25-dihydroxyvitamin D3 (calcitriol) |
| Downstream effect | Regulation of transcription via vitamin D response elements (VDREs) |
What Is GO:0070561?
GO:0070561 is defined as a nuclear receptor-mediated signaling pathway initiated by vitamin D binding to an intracellular receptor of the nuclear receptor protein family, and ending with regulation of a downstream cellular process, e.g. transcription. In simpler terms, it is the entire sequence of molecular events from vitamin D entering a cell and binding VDR to the subsequent changes in gene expression that affect cell behavior.
Why Is vitamin D receptor signaling pathway Important in Cell Biology?
The vitamin D receptor signaling pathway is essential for maintaining mineral homeostasis, bone health, and immune function, and its dysregulation contributes to a wide range of pathologies including cancer, inflammatory diseases, and metabolic disorders. Because VDR is a ligand-activated transcription factor, it serves as a paradigm for understanding nuclear receptor signaling and offers multiple points for therapeutic intervention. Research into this pathway has revealed cross-talk with other major signaling cascades such as JAK/STAT, Wnt, and Hippo, highlighting its integrative role in cellular decision-making.
• Regulates calcium and phosphate absorption, bone mineralization, and skeletal integrity.
• Modulates innate and adaptive immunity, influencing susceptibility to infections and autoimmune diseases.
• Controls cell cycle progression, apoptosis, and differentiation, with tumor-suppressive effects in several cancers.
• Protects against intestinal dysbiosis and tumorigenesis via JAK/STAT signaling.
• Ameliorates colitis by suppressing necroptosis of intestinal epithelial cells.
• Attenuates renal tubular epithelial cell ferroptosis in diabetic nephropathy through Nrf2/HO-1 signaling.
• Influences psoriasis pathogenesis via Wnt signaling pathway molecules.
• Modulates Hippo pathway effectors and cell survival in metastatic neuroblastoma.
• Provides a target for therapeutic modulation with vitamin D analogs and VDR ligands.
• Serves as a model for studying nuclear receptor-mediated transcription and gene regulation.
What Happens During vitamin D receptor signaling pathway?
Ligand Binding and VDR Activation
In simple terms: Vitamin D enters the cell and binds to the VDR, causing the receptor to change shape and become active.
The pathway begins when 1,25-dihydroxyvitamin D3 (calcitriol), the active form of vitamin D, diffuses across the cell membrane and binds to the ligand-binding domain of the vitamin D receptor (VDR) in the cytoplasm or nucleus. This binding induces a conformational change in VDR that releases corepressors and promotes heterodimerization with the retinoid X receptor (RXR). The ligand-bound VDR-RXR complex is then competent to bind DNA and regulate transcription.
Heterodimerization with RXR and DNA Binding
In simple terms: The activated VDR pairs with another receptor called RXR and together they attach to specific DNA sequences.
Upon ligand binding, VDR forms a heterodimer with RXR, and this complex translocates to the nucleus where it binds to vitamin D response elements (VDREs) in the promoter regions of target genes. VDREs typically consist of two hexameric repeats separated by three nucleotides (DR3-type). The binding of VDR-RXR to VDREs is a key step that recruits coactivator proteins and initiates chromatin remodeling.
Transcriptional Regulation of Target Genes
In simple terms: The VDR-RXR complex turns genes on or off, changing the cell's behavior.
Once bound to VDREs, the VDR-RXR heterodimer recruits coactivator complexes with histone acetyltransferase activity, leading to chromatin decompaction and increased transcription of target genes such as CYP24A1, TRPV6, and osteocalcin. VDR can also repress gene expression by recruiting corepressors. The net effect is a coordinated change in gene expression programs that control calcium transport, immune responses, and cell growth.
Cross-talk with Other Signaling Pathways
In simple terms: VDR signaling communicates with other cellular pathways to fine-tune responses.
VDR signaling intersects with multiple other pathways. For example, VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating the Nrf2/HO-1 signaling pathway in diabetic nephropathy. In intestine, VDR protects against dysbiosis and tumorigenesis via the JAK/STAT pathway. VDR signaling also ameliorates colitis by suppressing necroptosis of intestinal epithelial cells. In psoriasis, VDR expression correlates with Wnt signaling pathway molecules, and in neuroblastoma, VDR activation attenuates Hippo pathway effectors and cell survival. These interactions highlight the integrative role of VDR signaling in cellular physiology.
Key Genes Involved in GO:0070561 vitamin D receptor signaling pathway
The following genes and proteins are central to the vitamin D receptor signaling pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDR | Nuclear receptor that binds vitamin D and mediates transcriptional regulation | Core component; target for knockout, point mutation, and overexpression studies |
| RXRA | Retinoid X receptor alpha; heterodimerization partner of VDR | Essential for DNA binding and transcriptional activity; knockout models impair VDR signaling |
| RXRB | Retinoid X receptor beta; alternative heterodimerization partner | Modulates VDR signaling in specific tissues |
| CYP24A1 | Vitamin D 24-hydroxylase; primary VDR target gene | Feedback regulation of vitamin D levels; biomarker of VDR activity |
| CYP27B1 | 25-hydroxyvitamin D3 1-alpha-hydroxylase; produces calcitriol | Regulates ligand availability; knockout causes vitamin D-dependent rickets |
| TRPV6 | Calcium channel; VDR target gene | Mediates intestinal calcium absorption; knockout affects bone density |
| S100G | Calbindin-D9k; calcium-binding protein; VDR target | Facilitates calcium transport; marker of VDR transcriptional activity |
| BGLAP | Osteocalcin; bone matrix protein; VDR target | Marker of bone formation; regulated by VDR signaling |
| JAK1 | Janus kinase 1; mediates cytokine signaling | Cross-talks with VDR in intestinal immunity |
| STAT1 | Signal transducer and activator of transcription 1 | VDR modulates JAK/STAT pathway in intestine |
| Nrf2 (NFE2L2) | Transcription factor regulating antioxidant response | VDR activation regulates Nrf2/HO-1 signaling in diabetic nephropathy |
| HMOX1 | Heme oxygenase-1; antioxidant enzyme | Downstream effector of VDR-Nrf2 axis |
| RIPK1 | Receptor-interacting protein kinase 1; necroptosis regulator | VDR signaling suppresses necroptosis in colitis |
| RIPK3 | Receptor-interacting protein kinase 3; necroptosis regulator | Involved in VDR-mediated protection against colitis |
| MLKL | Mixed lineage kinase domain-like pseudokinase; necroptosis executor | VDR signaling inhibits MLKL phosphorylation in intestinal epithelial cells |
| YAP1 | Yes-associated protein 1; Hippo pathway effector | VDR activation attenuates YAP1 in neuroblastoma |
| CTNNB1 | Beta-catenin; Wnt signaling component | VDR expression correlates with Wnt molecules in psoriasis |
How Is vitamin D receptor signaling pathway Regulated?
VDR signaling is tightly regulated at multiple levels. Ligand availability is controlled by CYP27B1 (activating) and CYP24A1 (inactivating) enzymes. VDR expression itself is modulated by hormones, cytokines, and vitamin D status. Post-translational modifications of VDR, including phosphorylation, ubiquitination, and sumoylation, affect its stability and transcriptional activity. Coregulator proteins (coactivators and corepressors) dynamically regulate VDR target gene expression. Additionally, cross-talk with other signaling pathways such as JAK/STAT, Nrf2/HO-1, Wnt, and Hippo provides context-dependent regulation.
vitamin D receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VDR | Cancer (various types) | VDR knockout or overexpression in cancer cell lines; xenograft models |
| VDR | Inflammatory bowel disease | Intestinal epithelial cell-specific VDR knockout mice; DSS-induced colitis |
| VDR | Diabetic nephropathy | Renal tubular epithelial cells with VDR knockout or activation; diabetic mouse models |
| VDR | Psoriasis | Keratinocyte-specific VDR knockout; imiquimod-induced psoriasis model |
| VDR | Neuroblastoma | VDR activation in neuroblastoma cell lines; YAP1 knockdown |
Cancer
VDR signaling exerts tumor-suppressive effects in multiple cancers by inhibiting proliferation, inducing differentiation, and promoting apoptosis. In metastatic neuroblastoma, VDR activation attenuates Hippo pathway effectors and reduces cell survival. In intestinal cancer, VDR protects against dysbiosis and tumorigenesis via the JAK/STAT pathway. These findings suggest that VDR agonists may have therapeutic potential in oncology.
Inflammatory Bowel Disease
Intestinal VDR signaling ameliorates dextran sulfate sodium-induced colitis by suppressing necroptosis of intestinal epithelial cells. VDR also protects against dysbiosis and tumorigenesis in the intestine through JAK/STAT pathway modulation. These studies highlight the importance of VDR signaling in maintaining intestinal barrier integrity and immune homeostasis.
Diabetic Nephropathy
VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating the Nrf2/HO-1 signaling pathway in diabetic nephropathy. This suggests that VDR agonists could be beneficial in preventing kidney damage in diabetes.
Psoriasis
Immunohistochemical expression of VDR and Wnt signaling pathway molecules is altered in psoriasis, indicating a role for VDR signaling in the pathogenesis of this inflammatory skin disease. Vitamin D analogs are already used topically for psoriasis, underscoring the clinical relevance of this pathway.
From vitamin D receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does VDR loss affect intestinal tumorigenesis? | VDR knockout mice (germline or conditional) |
| What is the role of VDR ligand binding in calcium homeostasis? | VDR point mutation (ligand-binding domain) knock-in mice |
| How does VDR activation affect neuroblastoma survival? | VDR overexpression in neuroblastoma cell lines |
| Does VDR signaling regulate necroptosis in colitis? | Intestinal epithelial cell-specific VDR knockout mice |
| Can VDR activation prevent diabetic nephropathy? | Renal tubular cell-specific VDR knockout or overexpression in diabetic mice |
| What are the transcriptional targets of VDR in immune cells? | Tagged VDR knock-in for ChIP-seq in macrophages |
How to Study the vitamin D receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify VDR target genes and pathways |
| ChIP-seq | Genome-wide VDR binding sites | Map VDREs and transcriptional regulation |
| Proteomics | Protein expression and modifications | Discover cross-talk with other pathways |
| CRISPR knockout | Loss-of-function phenotypes | Determine causal role of VDR in disease models |
| CRISPR point mutation | Specific amino acid changes | Study ligand binding or DNA binding domains |
| CRISPR knock-in | Tagged or reporter alleles | Track VDR localization and interactions |
| Overexpression | Gain-of-function effects | Assess VDR activation in cancer or inflammation |
| Immunohistochemistry | Protein expression and localization | Evaluate VDR and Wnt molecules in psoriasis |
Transcriptomic Analysis (RNA-seq)
RNA sequencing is widely used to identify VDR target genes and global transcriptional changes upon VDR activation or knockout. This method reveals pathways modulated by VDR signaling, such as Nrf2/HO-1, JAK/STAT, and Wnt.
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ChIP-seq for VDR identifies genome-wide binding sites of the VDR-RXR complex at VDREs, providing a map of direct transcriptional regulation. This is essential for understanding the primary response to vitamin D.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry-based proteomics can quantify changes in protein expression and post-translational modifications following VDR activation, revealing cross-talk with signaling cascades such as JAK/STAT and Hippo.
CRISPR-Cas9 Genome Editing
CRISPR knockout, point mutation, and knock-in models are used to dissect the causal roles of VDR and its partners in cellular and animal models. These approaches enable precise genetic manipulation to study VDR signaling in health and disease.
How CRISPR Can Be Used to Study GO:0070561 vitamin D receptor signaling pathway
Knockout
CRISPR-Cas9 knockout of VDR or its heterodimerization partners (e.g., RXRA) is used to abolish pathway activity and study loss-of-function phenotypes in cell lines and animal models. For example, VDR knockout mice have been instrumental in revealing roles in intestinal tumorigenesis and colitis.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions in VDR to dissect domain functions, such as ligand binding or DNA binding. These models help distinguish between different VDR activities and their contributions to disease.
Knock-in
Knock-in of tagged VDR (e.g., GFP or HA) allows for real-time tracking of VDR localization and interaction partners using imaging and proteomics. Knock-in of reporter genes under VDR target promoters (e.g., CYP24A1) enables high-throughput screening for VDR modulators.
Overexpression
Overexpression of VDR or constitutively active VDR mutants is used to enhance pathway activity and study gain-of-function effects in cancer and inflammation models. This approach can identify protective roles of VDR signaling in disease.
How EDITGENE Supports vitamin D receptor signaling pathway Research
Researchers studying vitamin D receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to create precise genetic models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for vitamin D receptor signaling pathway research.
Frequently Asked Questions About vitamin D receptor signaling pathway
What is the vitamin D receptor signaling pathway?
It is a biological process (GO:0070561) where vitamin D binds to the intracellular VDR, leading to regulation of gene transcription and downstream cellular responses.
What genes are involved in vitamin D receptor signaling pathway?
Key genes include VDR, RXRA, RXRB, CYP24A1, CYP27B1, TRPV6, and S100G, among others.
How does VDR signaling work?
Vitamin D binds VDR, which heterodimerizes with RXR and binds VDREs in DNA to activate or repress target genes.
What diseases are associated with VDR signaling?
Cancer, inflammatory bowel disease, diabetic nephropathy, psoriasis, and neuroblastoma are linked to VDR signaling dysregulation.
What is the role of VDR in cancer?
VDR signaling exerts tumor-suppressive effects by inhibiting proliferation, inducing differentiation, and promoting apoptosis.
How is VDR signaling studied?
Common methods include RNA-seq, ChIP-seq, proteomics, and CRISPR-Cas9 genome editing.
What are vitamin D response elements (VDREs)?
VDREs are specific DNA sequences in gene promoters where the VDR-RXR complex binds to regulate transcription.
Can VDR signaling be targeted therapeutically?
Yes, vitamin D analogs and VDR ligands are being explored for cancer, autoimmune diseases, and metabolic disorders.
What is the difference between VDR and RXR?
VDR is the vitamin D receptor, while RXR is its heterodimerization partner; together they form the active transcription factor complex.
How does VDR signaling interact with other pathways?
VDR signaling cross-talks with Nrf2/HO-1, JAK/STAT, Wnt, and Hippo pathways, influencing diverse cellular outcomes.
Conclusion
The vitamin D receptor signaling pathway (GO:0070561) is a fundamental nuclear receptor pathway with broad physiological and pathological implications. Its core mechanism involves ligand-dependent activation of VDR, heterodimerization with RXR, and transcriptional regulation of target genes. Dysregulation contributes to cancer, inflammatory diseases, and metabolic disorders, making it a prime target for therapeutic intervention. CRISPR-based models are invaluable for dissecting causal roles of pathway components and accelerating drug discovery.
References
- 1. Christakos S et al.. 2016. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.. Physiol Rev 96(1):365-408 PMID: 26681795
- 2. Wang H et al.. 2024. VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO-1 Signaling Pathway in Diabetic Nephropathy.. Adv Sci (Weinh) 11(10):e2305563 PMID: 38145959
- 3. Campbell MJ et al.. 2017. Vitamin D Receptor Signaling and Cancer.. Endocrinol Metab Clin North Am 46(4):1009-1038 PMID: 29080633
- 4. Ismaeel A et al.. 2023. Immunohistochemical expression of vitamin D receptor and Wnt signaling pathway molecules in psoriasis.. Acta Dermatovenerol Alp Pannonica Adriat 32(4):129-133 PMID: 38126094
- 5. Ladumor Y et al.. 2022. Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.. Mol Cancer Res 20(6):895-908 PMID: 35190818
- 6. Nguyen TT et al.. 2026. Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications.. Int J Mol Sci 27(5) PMID: 41828612
- 7. Zhang YG et al.. 2020. Vitamin D Receptor Protects Against Dysbiosis and Tumorigenesis via the JAK/STAT Pathway in Intestine.. Cell Mol Gastroenterol Hepatol 10(4):729-746 PMID: 32497792
- 8. Shi Y et al.. 2020. Intestinal vitamin D receptor signaling ameliorates dextran sulfate sodium-induced colitis by suppressing necroptosis of intestinal epithelial cells.. FASEB J 34(10):13494-13506 PMID: 32779265
